[ASBMR 2010 report. Meeting report on the ASBMR. Obstacles in medicine for osteoporosis]. [electronic resource]
- Clinical calcium Jan 2011
- 104-8 p. digital
Publication Type: Congress
0917-5857
CliCa1101104108 doi
Antibodies, Monoclonal--therapeutic use Antibodies, Monoclonal, Humanized Bone Density Conservation Agents--adverse effects Bone and Bones--metabolism Cathepsin K--antagonists & inhibitors Denosumab Diphosphonates--adverse effects Drug Design Enzyme Inhibitors--therapeutic use Femoral Fractures--etiology Humans Osteoporosis--drug therapy Proton Pump Inhibitors--adverse effects RANK Ligand--therapeutic use Risk Factors Selective Serotonin Reuptake Inhibitors--adverse effects Societies, Medical Vitamin D--analogs & derivatives